Outcome measure domain | Studies reported the outcome measure (n/42) | Variable subdomains of outcome measure | Variable outcome measurements | References |
---|---|---|---|---|
Visual acuity | 36 (86%) | BCVA (median/ mean change,IOD,≥2 line improvement) 38 Uncorrected Distance Visual Acuity UDVA 1 Near Visual Acuity 1 Binocular VA 1 | Age appropriate test 23 HOTV 7 ETDRS 5 Snellen eye chart 4 The Crowded Acuity Test (Glasgow Acuity Test) 2 Tumbling E charts 2 Bailey-Lovie 1 Allen Figs. 1 | [3, 11,12,13,14,15,16,17,18,19,20, 22,23,24,25,26,27,28,29,30,31,32,33,34, 36,37,38,39,40, 43,44,45,46,47,48] |
Stereopsis | 17 (40%) | Near Stereopsis/ binocularity/sensory outcomes 16 Stereo sensitivity 1 | Randot Preschool Stereoacuity Test 4 Lang stereo test II 2 Bagolini glasses response (at near & distance) 2 The Frisby test 2 | [11, 12, 15, 20, 23,24,25,26,27,28, 31, 34, 36, 39, 42, 45, 48] |
Adverse events | 14 (33%) | |||
Health-related quality of life | 9 (21%) | HRQoL 9 Emotional impact 1 Social stigma scores 1 | Amblyopia Treatment Index 4 Amblyopia and Strabismus Q 2 Psychological Impact Q 2 Patching Success Q 1 CVFQ 1 SPPC 1 VF-14 1 Protection Motivation Theory Q 1 Interviews 1 Mean Rutter behaviour scores 1 | |
Compliance | 8 (19%) | Objective occlusion dose monitoring 3 Parental treatment diaries 2 | ||
Refractive outcomes | 5 (12%) | Median spherical equivalent 3 Refractive outcome 2 Spherical and cylindrical refraction 1 | Manifest and cycloplegic refractions 1 | |
Ocular alignment | 5 (12%) | Simultaneous prism and Cover test SPCT 4 Cover test 1 | ||
Economic data | 3 (7%) | Cost data 3 Cost- effectiveness 1 | ||
Visual evoked potentials | 2 (5%) | M-VEP amplitude & latency 1 VEP latency 1 | ||
Detection by Photoscreeners | 1 (2%) | MTI photoscreener 1 PowerRefractor 1 PowerRefractor II 1 Plusoptix photoscreener series 1 iScreen 1 Spot 1 | [1] |